BNP facilitates NMB-encoded histaminergic itch via NPRC-NMBR crosstalk
Figures

Expression of Npr1, 2,and 3 and other molecular markers in the spinal cord.
(A) Diagram shows crosstalk between NPs and NP receptors. BNP can bind NPRA and NPRC. (B) BNP dose-dependently evoked scratching behaviors 60 min after i.t. injection. n = 6. *p < 0.05, **p < 0.01, one-way ANOVA followed by Tukey’s test. (C) Time-course of scratching behaviors induced by different doses of BNP shows a delayed onset of scratching responses. (D, F, H, J, L, N) Images of double RNAscope ISH showing that the overlapping expression of Npr1 (green) with Grpr (red) (D), Nmbr (F), of Npr3 (green) with Nmbr (red) (H), Npr3 (red) with Vglut2 (green) (J), Vgat (green) (L), or Npr1 (green) (N) in laminae I-II of the dorsal horn. Dashed white lines divide laminae I-II from III. White boxes are shown at higher magnification in the right panel. Arrows indicate double-positive neurons. E, G, I, K, M, O, Venn diagrams showing the overlap between Npr1 and Grpr (E), Nmbr (G), between Npr3 and Nmbr (I), Vglut2 (K), Vgat (M) or Npr1 (O). n = 10–15 sections from 3 mice. Scale bar, 20 µm in D – N.
-
Figure 1—source data 1
BNP dose-dependently evoked scratching behaviors and showed a delayed onset of scratching responses.
- https://cdn.elifesciences.org/articles/71689/elife-71689-fig1-data1-v2.xlsx

Failure of ANP and CNP in facilitating histamine itch.
(A) ANP 1 ~ 20 µg, (equivalent to 6–120 µM, i.t.) failed to induce robust scratching behaviors in mice. n = 6. (B) Only BNP (30 µM, i.t.) facilitated histamine itch. Note that neither ANP (60 µM, i.t.) nor CNP (60 µM, i.t.) exhibited facilitatory effect. n = 6–7. *p < 0.05, ***p < 0.001, one-way ANOVA followed by Dunnett’s test. Values are presented as mean ± SEM.
-
Figure 1—figure supplement 1—source data 1
Failure of ANP and CNP in facilitating histamine itch.
- https://cdn.elifesciences.org/articles/71689/elife-71689-fig1-figsupp1-data1-v2.xlsx

Normal innervation of primary afferents in Npr1 KO mice and WT mice.
(A-D) Comparable expression of CGRP (red) and IB4 staining (green), TRPV1, GRP, and SP in the superficial dorsal horn of WT and Npr1 KO mice. Scale bar, 50 µm. (E) Images of double RNAscope ISH showing that Npr1 (green) is partially co-expressed with Grp (red) in the dorsal horn. Arrows indicate double-positive neurons. Scale bar, 20 µm. (F) Venn diagram showing partial overlapping of Npr1 and Grp expression. (G) Scratching behaviors elicited by i.t. BNP (150 µM) were significantly enhanced by isoflurane. (H) Time course of i.t. NMB (1 nmol) and GRP (1 nmol) evoked scratching behavior. n = 6. **p < 0.01, ***p < 0.001, two-way ANOVA followed by Bonferroni’s test. Values are presented as mean ± SEM. Scale bar, 50 µm in A-D, 20 µm in E.
-
Figure 1—figure supplement 2—source data 1
Time course of NMB and GRP evoked scratching behavior.
- https://cdn.elifesciences.org/articles/71689/elife-71689-fig1-figsupp2-data1-v2.xlsx

NPRA and NPRC are involved in acute itch.
(A) Npr1 KO mice and their WT littermates showed comparable scratching behaviors in response to GRP (0.05 nmol, i.t.) and NMB (0.5 nmol, i.t.). n = 6–8. (B) Npr1 KO mice showed significantly reduced scratching behavior elicited by histamine (200 µg, i.d.) and CQ (200 µg, i.d.). n = 9–11. *p < 0.05, **p < 0.01, unpaired t test. (C, D) Mice treated with Npr1 siRNA showed significantly reduced scratching responses to histamine (C), CQ (D), wherea mice treated with Npr3 siRNA displayed deficits only in histamine (C) but not CQ itch (D). n = 6–7. *p < 0.05, **p < 0.01, one-way ANOVA followed by Dunnett’s test. (E, F) Real-time PCR confirmed the reduced Npr1-3 expression by Npr1, Npr2, and Npr3 siRNA knockdown in the spinal cord (E) and DRG (F). n = 4. **p < 0.01, one-way ANOVA followed by Dunnett’s test. Values are presented as mean ± SEM.
-
Figure 2—source data 1
NPRA and NPRC are involved in acute itch.
- https://cdn.elifesciences.org/articles/71689/elife-71689-fig2-data1-v2.xlsx

BNP facilitates histamine itch.
(A) Pre-injection of BNP (30 µM, i.t.) for 1 min significantly enhanced scratching behavior evoked by i.d. injection of histamine (Hist.) (100 µg). n = 6. (B) Scratching behavior evoked by i.d. injection of CQ (50 µg, i.d.) was significantly enhanced by pre-injection of BNP for 1 min. n = 6. (C, D) Co-injection of 1 µg BNP (30 µM, i.t.) facilitated scratching behaviors evoked by NMB (0.05 nmol, i.t.) (C) but not GRP (0.01 nmol) (D). n = 6. (E) Pre-injection of 1 µg BNP (30 µM, i.t.) for 1 min significantly enhanced scratching behavior evoked by i.d. injection of histamine (100 µg) in Grpr KO mice. n = 8. (F, G) Pre-injection of NMB (0.05 nmol, i.t.) had no effect on scratching behavior induced by histamine (F) or CQ (G). Note that NMB barely evoked scratching bouts. n = 6. (H), NPRC agonist ANP-4–23 (6 nmol, i.t.) facilitates NMB (0.005 nmol, i.t.) induced scratching behavior. n = 5–9. (I), Histamine (25 µg, i.d.)-induced scratching behavior facilitated by BNP (30 µM, i.t.) was attenuated with AP 811 (10 µM, i.t.) or U 73122 (13.5 nmol, i.t.) treatment. n = 6–11. (I–K) Double RNAScope ISH images (J and L) and Venn diagrams (K and M) showing 60% of Nppb neurons co-express Nmb (J and K), but little Grp in DRGs (L and M). Values are presented as mean ± SEM, *p < 0.05, **p < 0.01, unpaired t test in (A–E), one-way ANOVA in (F and G). Scale bar, 20 µm in J, 50 µm in L.
-
Figure 3—source data 1
BNP facilitates histamine itch.
- https://cdn.elifesciences.org/articles/71689/elife-71689-fig3-data1-v2.xlsx

Potentiation of NMB-evoked calcium and scratching responses by BNP requires Gi-Gq crosstalk between NPRC-NMBR.
(A) A diagram showing the procedure for calcium imaging on dissociated spinal cord dorsal horn neurons. (B) Sample traces showing that co-application of BNP and NMB at low doses evoked Ca2+ transients in WT dorsal horn neurons (n = 8 neurons from 33 NMBR neurons analyzed, n = 10 pups). These neurons responded to both BNP/NMB at the low doses responded to NMB at 20 nM robustly, indicating that they are healthy neurons. (C) No dorsal horn neurons responded to NMB (20 nM) isolated from the spinal cord of Nmbr KO mice (n = 2 mice), whereas they responded to KCI, indicating that they were healthy neurons. (D) Co-application of BNP (1 µM) with subthreshold of NMB (1 pM) evoked robust calcium response in HEK 293 cells co-expressing NMBR, which was significantly attenuated by Npr3 siRNA treatment. (E) Calcium transients induced by BNP and NMB were attenuated by pre-incubation of PTX (200 ng/ml), gallein or AP 811 (0.1 µM) for 30 min. n = 6 slides per group with at least 50 cells imaged on each slide. (F) Quantification of calcium concentration ([Ca2+]i) of E. (G) I.t. gallein (20 nmol) significantly reduced scratching behavior evoked by histamine (25 µg, i.d.) facilitated with BNP (30 µM, i.t.). Values are presented as mean ± SEM, n = 6–10. *p < 0.05, ***p < 0.001, one-way ANOVA followed by Tukey’s test.
-
Figure 4—source data 1
Potentiation of NMB-evoked calcium and scratching responses by BNP requires Gi-Gq crosstalk between NPRC-NMBR.
- https://cdn.elifesciences.org/articles/71689/elife-71689-fig4-data1-v2.xlsx

real-time RT-PCR detected endogenous expression of Npr1, Npr2, and Npr3 in HEK 293 cells.

BNP-sap ablates spinal cord neurons expressing Npr1 and Npr3.
(A-F) RNAscope ISH images (A and C) and quantified data (F) showing that BNP-sap ablated Npr1+ (A), Npr3+ (C), Grp+ (D), and Nmbr+ (E) neurons (red) in the dorsal horn of the spinal cord, while Npr2+ (B) neurons (red) were not affected. n = 4. (G) Incubation of BNP (10 µM) for 30 min caused internalization of Npr1-mCh and Npr3-mCh in HEK 293 cells transfected with NMBR cDNA as indicated by arrows. No internalization of Npr2-mCh was observed. Scale bar, 20 µm. mCh: mCherry. (H, I) Scratching behaviors induced by histamine (H), but not CQ (I) were significantly reduced in BNP-sap treated mice. n = 7–8. Values are presented as mean ± SEM. *p < 0.05, **p < 0.01, unpaired t test. Scale bar, 50 µm in A–F, 10 µm in G.
-
Figure 5—source data 1
BNP-sap ablates spinal cord neurons expressing Npr1 and Npr3.
- https://cdn.elifesciences.org/articles/71689/elife-71689-fig5-data1-v2.xlsx

SST evoked both pain and itch responses in mice.
(A) Pre-injection of morphine (10 mg/kg, i.p.) for 30 min attenuated scratching behaviors induced by i.t. injection of SST (5 nmol). n = 6 mice per group. Sal, saline; Mor, morphine. (B, C) SST (5 nmol, i.t.)(B) and OCT (C) -evoked scratching behaviors were significantly reduced in bombesin-saporin-treated mice comparing with control mice that were treated with blank saporin. n = 5–6 mice per group. Ctrl, control; BB-sap, bombesin-saporin. (D) Raster plot of scratching behavior induced by light stimulation of skin in Sst-ChR2 and Sst-cre mice. (E) Number of scratches in 5 min induced by 3 s – 1, 5, 10, or 20 Hz light stimulation of nape skin in Sst-ChR2 and Sst-cre mice. n = 8–10 mice. ns – not significant, one-way ANOVA with Tukey post hoc. (F) IHC images of Sst-ChR2/Sst co-expression in DRG of Sst-ChR2 mice (Left). Arrowheads indicate co-expression. Scale bar, 10 µm. Venn diagram showing overlapping expression of Sst-ChR2 and Sst in DRG neurons (Right). (G) IHC images of Sst-ChR2/CGRP/IB4 (left), Sst-ChR2/NF-H (middle), and Sst-ChR2/TRPV1 (right) in DRG of Sst-ChR2 mice. Arrowheads indicate co-expression. (H) IHC image of Sst-ChR2/βIII-Tubulin in hairy nape skin. Dashed line marks epidermal/dermal boundary. Arrowheads indicate ChR2 expression in lanceolate endings of hair follicles. Values are presented as mean ± SEM. *p < 0.05, **p < 0.01, unpaired t test. Scale bars, 10 µm in F, 100 µm in G and H.
-
Figure 6—source data 1
SST evoked both pain and itch responses in mice.
- https://cdn.elifesciences.org/articles/71689/elife-71689-fig6-data1-v2.xlsx

BNP-NPRA signaling is dispensable for nonhistaminergic itch and neuropathic itch.
(A) Npr1 KO mice and WT littermates showed comparable spontaneous scratching behaviors in the dry skin model. n = 6, p = 0.1283, F1,50 = 2.392, repeated measures Two-way ANOVA. (B) Real-time RT PCR showing significantly reduced levels of Grp, Nmb, Nppb, Sst, and Tac1 in DRGs of dry skin mice relative to WT mice. n = 4. (C), RNA scope ISH images showing that Nppb and Sst were largely co-expressed in WT DRG neurons. Nppb and Sst signals were dramatically reduced in DRGs of BRAFNav1.8 mice. (D) Venn diagram showing overlapping expression of Nppb and Sst. (E) Quantified data of RNA scope showing that the numbers of Nppb neurons and Sst neurons were significantly reduced in the DRGs of BRAFNav1.8 mice. n = 4. Values are presented as mean ± SEM. **p < 0.01, ***p < 0.001, unpaired t test. Scale bars, 50 µm.
-
Figure 6—figure supplement 1—source data 1
BNP-NPRA signaling is dispensable for histamine-independent chronic itch.
- https://cdn.elifesciences.org/articles/71689/elife-71689-fig6-figsupp1-data1-v2.xlsx
Optogenetic stimulation of skin of Sst-ChR2 mice failed to induce scratching behaviors.
Sample video showing that 20 Hz light stimulation failed to induce scratching behaviors.

Schematics for the BNP-NPRC facilitated signaling pathway and distinct neuropeptide pathways for histamine-dependent and -independent itch.
(A) A schematic showing a model for NMBR-NPRC cross-signaling facilitated by BNP via the NMB-NMBR pathway. In response to histamine, NMB and BNP are released from primary afferents to activate NMBR and NPRC concurrently. Activation of NMBR by NMB at a low concentration may prime PLCβ signaling, whereas activation of NPRC by BNP stimulates Gai signaling, which in turn stimulates PLCβ to activate downstream Ca2+ signaling. (B) A hypothetic model depicting the respective roles of neuropeptides and glutamate in itch transmission. CQ itch is mediated in part by GRP-GRPR signaling independent of glutamatergic transmission. In contrast, histamine itch is mediated by NMB-NMBR signaling from primary afferents to NMBR neurons and by glutamatergic transmission from NMBR neurons to GRPR neurons. BNP facilitates NMB-NMBR signaling via NPRC independent of GRP-GRPR signaling but dependent on GRPR neurons. Glu: glutamate; GRP: gastrin-releasing peptide; BNP: B-type natriuretic peptide; NMB: neuromedin B.

A hypothetic model depicting the role of BNP, NMB, and SST in facilitation of itch and disinhibition of pain, respectively.
In response to histamine injection, NMB is released from primary afferents to activate NMBR neurons, while BNP is released to activate NPRC to facilitate NMBR signaling in NMBR neurons. Note that NMB and BNP do not have to be released from the same sensory neurons since NMB is also expressed in non-BNP neurons that may also innervate NMBR/NPRC neurons. During itch transmission, SST is not released. However, in response to certain types of noxious stimuli, SST may be released due to more intense firing of primary afferents to inhibit SST2R neurons, contributing to nociceptive transmission as a result of disinhibition.
Tables
Reagent type(species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Strain, strain background (Mus musculus) | C57BI/6 mice | The Jackson Laboratory | Cat#000664 | NA |
Strain, strain background (Mus musculus) | Npr1 KO | The Jackson Laboratory | Cat#004374 | NA |
Strain, strain background (Mus musculus) | Grpr KO mice | The Jackson Laboratory | Cat#003126 | NA |
Strain, strain background (Mus musculus) | Nmbr KO | Ohki-Hamazaki et al., 1999 | NA | NA |
Strain, strain background (Mus musculus) | Ai32 (Gt(ROSA)26Sortm32(CAG-OP4*H134R/EYFP)Hze) | The Jackson Laboratory | Cat#024109 | NA |
Strain, strain background (Mus musculus) | SstCre | The Jackson Laboratory | Cat#018973 | NA |
Cell line (human) | HEK 293 | ATCC | Cat#CRL-1573 | NA |
Antibody | Rabbit anti-CGRPα(Rabbit polyclonal) | Millipore | Cat#AB1971 | IF (1/3000) |
Antibody | Guinea pig anti-Substance P(Guinea pig polyclonal) | Abcam | Cat#ab10353 | IF (1/1000) |
Antibody | Guinea pig anti-TRPV1(Guinea pig polyclonal) | Neuromics | Cat#GP14100 | IF (1/1000) |
Antibody | Chicken anti-NF-H(Chicken polyclonal) | EnCor Biotechnology | Cat#CPCA-NF-H | IF (1/2000) |
Antibody | Rabbit anti-βIII-Tubulin(Rabbit polyclonal) | Biolegend | Cat#802,001 | IF (1/2000) |
Antibody | Rabbit anti-GFP(Rabbit polyclonal) | Molecular Probes | Cat#A11122 | IF (1/1000) |
Antibody | Chicken anti-GFP(Chicken polyclonal) | Aves Labs | Cat#GFP-1020 | IF (1/500) |
Antibody | FITC-conjugated Isolectin B4 (Polyclonal) | Sigma | Cat#L2895 | IF (1/500) |
Antibody | IB4-AlexaFluor 568 conjugate (Polyclonal) | ThermoFisher Scientific | Cat#I21412 | IF (1/500) |
Antibody | Cy3 conjugated donkey anti-mouse IgG (Polyclonal) | Jackson ImmunoResearch | Cat#715-165-150 | IF (1/500) |
Antibody | Cy3 conjugated donkey anti-chicken IgG (Polyclonal) | Jackson ImmunoResearch | Cat#703-165-155 | IF (1/500) |
Antibody | Cy3 conjugated donkey anti-rabbit IgG (Polyclonal) | Jackson ImmunoResearch | Cat#711-165-152 | IF (1/500) |
Antibody | Cy3 conjugated donkey anti-guinea pig IgG (Polyclonal) | Jackson ImmunoResearch | Cat#706-165-148 | IF (1/500) |
Antibody | Cy5 conjugated donkey anti-mouse pig IgG (Polyclonal) | Jackson ImmunoResearch | Cat#715-175-150 | IF (1/500) |
Antibody | Cy5 conjugated donkey anti-chicken IgG (Polyclonal) | Jackson ImmunoResearch | Cat#703-175-155 | IF (1/500) |
Antibody | Cy5 conjugated donkey anti-rabbit IgG (Polyclonal) | Jackson ImmunoResearch | Cat#711-175-152 | IF (1/500) |
Antibody | Cy5 conjugated donkey anti-guinea pig IgG (Polyclonal) | Jackson ImmunoResearch | Cat#706-175-148 | IF (1/500) |
Antibody | FITC conjugated donkey anti-mouse IgG (Polyclonal) | Jackson ImmunoResearch | Cat# 715-095-150 | IF (1/500) |
Antibody | FITC conjugated donkey anti-chicken IgG (Polyclonal) | Jackson ImmunoResearch | Cat#703-095-155 | IF (1/500) |
Antibody | FITC conjugated (Polyclonal)donkey anti-rabbit IgG | Jackson ImmunoResearch | Cat#111-095-144 | IF (1/500) |
Antibody | FITC conjugated donkey anti-guinea pig IgG (Polyclonal) | Jackson ImmunoResearch | Cat#706-095-148 | IF (1/500) |
Peptide, recombinant protein | ANP | GenScript | Cat#RP11927 | 5–10 μg, i.t. |
Peptide, recombinant protein | BNP | GenScript | Cat#RP11119 | 1–5 μg, i.t. |
Peptide, recombinant protein | CNP | GenScript | Cat#RP11110 | NA |
Peptide, recombinant protein | SST | GenScript | Cat#RP10230 | 5 nmol, i.t. |
Peptide, recombinant protein | OCT | GenScript | Cat#SMS 201–995 | NA |
Peptide, recombinant protein | GRP18-27 | Bachem | Cat#H-3120.0005 | NA |
Peptide, recombinant protein | NMB | Bachem | Cat#H-3280.0001 | 0.5 nmol, i.t. |
Chemical compound, drug | Histamine | Sigma | Cat#H7250 | 100 μg, i.d. |
Chemical compound, drug | Chloroquine | Sigma | Cat#C6628 | 200 μg, i.d. |
Chemical compound, drug | BNP-saporin (BNP-sap) | Advanced Targeting Systems | Cat#IT-69 | 2.5 μg/mouse, i.t |
Chemical compound, drug | Blank-saporin | Advanced Targeting Systems | Cat#IT-27B | NA |
Chemical compound, drug | Pertussis toxin (PTX) | R&D Systems | Cat#3,097 | 200 ng/ml |
Chemical compound, drug | Gallein | R&D Systems | Cat#3,090 | 100 μM, 2 mM calcium imaing |
Chemical compound, drug | Acetone | Sigma | Cat#179,124 | NA |
Chemical compound, drug | AP 811 | Tocris | Cat#5,498 | 10 µM, i.t. |
Chemical compound, drug | ANP 4–23 | Bachem | Cat#4030384 | 10 µg, i.t. |
Chemical compound, drug | U73122 | Selleck | Cat#S8011 | 13.5 nmol, i.t. |
Chemical compound, drug | Gallein | Selleck | S5978 | 20 nmol, i.t., behavior study |
Chemical compound, drug | Ddiethyl ether | Sigma | Cat#309,966 | NA |
Sequence-based reagents | RNAscope Fluorescent Multiplex Assay v2 | Advanced Cell Diagnostics | Cat#323,110 | NA |
Sequence-based reagents | RNAscope probe Mm_Nppb | Advanced Cell Diagnostics | Cat#425,021 | NA |
Sequence-based reagents | RNAscope probe Mm_Npr1 | Advanced Cell Diagnostics | Cat#484,531 | NA |
Sequence-based reagents | RNAscope probe Mm_Npr2 | Advanced Cell Diagnostics | Cat#315,951 | NA |
Sequence-based reagents | RNAscope probe Mm_Npr3 | Advanced Cell Diagnostics | Cat#502,991 | NA |
Sequence-based reagents | RNAscope probe Mm_Grp | Advanced Cell Diagnostics | Cat#317,861 | NA |
Sequence-based reagents | RNAscope probe Mm_Grpr | Advanced Cell Diagnostics | Cat#317,871 | NA |
Sequence-based reagents | RNAscope probe Mm_Nmbr | Advanced Cell Diagnostics | Cat#406,461 | NA |
Sequence-based reagents | RNAscope probe Mm_Vgat | Advanced Cell Diagnostics | Cat#319,191 | NA |
Sequence-based reagents | RNAscope probe Mm_Vglut2 | Advanced Cell Diagnostics | Cat#319,171 | NA |
Sequence-based reagents | Npr1 siRNA | Sigma | Cat#SASI_Mm01_00106966 | 2 μg/μL, i.t. |
Sequence-based reagents | Npr2 siRNA | Sigma | Cat#SASI_Mm01_00201357 | 2 μg/μL, i.t. |
Sequence-based reagents | Npr3 siRNA | Sigma | Cat#SASI_Mm01_00036567 | 2 μg/μL, i.t. |
Sequence-based reagents | Nppb primer for RT-PCR:5’- GTCAGTCGTTTGGGCTGTAAC-3’,5’- AGACCCAGGCAGAGTCAGAA-3’ | IDT | PCR primers | NA |
Sequence-based reagents | Sst primer for RT-PCR:5’- CCCAGACTCCGTCAGTTTCT –3’,5’- CAGCAGCTCTGCCAAGAAGT –3’ | IDT | PCR primers | NA |
Sequence-based reagents | Npr1 primer for RT-PCR:5’- TGGAGACACAGTCAACACAGC-3’,5’- CGAAGACAAGTGGATCCTGAG-3’ | IDT | PCR primers | NA |
Sequence-based reagents | Npr2 primer for RT-PCR:5’- TGAGCAAGCCACCCACTT-3’,5’- AGGGGGCCGCAGATATAC-3’ | IDT | PCR primers | NA |
Sequence-based reagents | Npr3 primer for RT-PCR:5’- TGCACACGTCTGCCTACAAT-3’,5’- GCACCGCCAACATGATTCTC –3’ | IDT | PCR primers | NA |
Sequence-based reagents | Grpr primer for RT-PCR:5’-TGATTCAGAGTGCCTACAATCTTC-3’,5’-TTCCGGGATTCGATCTG-3’ | IDT | PCR primers | NA |
Sequence-based reagents | Nmbr primer for RT-PCR:5’- GGGGGTTTCTGTGTTCACTC –3’,5’- CATGGGGTTCACGATAGCTC –3’ | IDT | PCR primers | NA |
Sequence-based reagents | Actb primer for RT-PCR:5’-TGTTACCAACTGGGACGACA-3’,5’-GGGGTGTTGAAGGTCTCAAA-3’ | IDT | PCR primers | NA |
Sequence-based reagents | Gapdh primer for RT-PCR:5’-CCCAGCAAGGACACTGAGCAA-3’,5’-TTATGGGGGTCTGGGATGGAAA-3’ | IDT | PCR primers | NA |
Software and algorithms | Prism 6 | GraphPad Software | https://www.graphpad.com/ | NA |
Software and algorithms | ImageJ | NIH | https://imagej.nih.gov/ij | NA |
Software and algorithms | Nikon Elements Software | Nikon | https://www.microscope.healthcare.nikon.com/products/software/nis-elements | NA |